ArticleBiochemistry and biophysics reports2022

CRISPR/Cas9 disruption of EpCAM Exon 2 results in cell-surface expression of a truncated protein targeted by an EpCAM specific T cell engager.

Andisheh Bagheri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.